Sindhu Chandran
Cedars-Sinai Medical Center · University of California San Francisco School of Medicine: Transplantation · Immune Tolerance Network (ITN)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sindhu Chandran as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06919003 · Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)National Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Kidney Transplant · study chair
- Ph1/Ph2NCT04066114 · Treg Modulation With CD28 and IL-6 Receptor AntagonistsNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Living-Donor Kidney Transplant, Kidney Transplant Recipients · study chair
- N/ANCT02743793 · A Cohort Study of Operationally Tolerant Allograft RecipientsNational Institute of Allergy and Infectious Diseases (NIAID) · terminated · Kidney Transplant, Liver Transplant · study chair
- Ph1/Ph2NCT02711826 · Treg Therapy in Subclinical Inflammation in Kidney TransplantationNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Immune Tolerance NetworkUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · fiscal years 2014 to 2026Named on NCT02743793
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:53 UTC. The ranking covers the 200 most relevant of 34 PubMed records, and a shared surname and initials can bring in a namesake. All 34 on PubMed
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.Lancet Neurol · 2012467 citationsRCR 14.4
- Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.Lancet Oncol · 2017233 citationsRCR 6.7
- Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.Am J Transplant · 2017192 citationsRCR 6.2
- Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial.Lancet Neurol · 2020104 citationsRCR 5.6
- 92 citationsRCR 5.5
- 91 citationsRCR 2.6
- Complications of Ultrasound-Guided Renal Transplant Biopsies.Am J Transplant · 201686 citationsRCR 4.3
- Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial.Am J Transplant · 202162 citationsRCR 3.8
- 47 citationsRCR 2.1
- 42 citationsRCR 9.6